Photo of David T. Fischer

David T. Fischer

Special Counsel
Washington, DC
F: +1.202.747.3914


  • J.D., Georgetown University Law Center, 1999
  • B.A., Miami University, 1996
  • District of Columbia
  • Ohio
  • U.S. Court of Appeal for the District of Columbia Circuit
  • U.S. Court of Appeal for the Sixth Circuit
  • U.S. District Court for the District of Columbia
  • U.S. District Court for the Southern District of Ohio
  • U.S. Court of Appeals for Veterans Claims
Thought Leadership


David T. Fischer is a special counsel in the Government Contracts, Investigations & International Trade Practice Group in the firm's Washington, D.C. office.

Areas of Practice

David's practice focuses on representing individuals and companies in civil and regulatory government enforcement actions, including false claims act and antitrust matters. David has represented both plaintiffs and defendants in these matters, including qui tam whistleblowers in False Claims Act matters, and has conducted internal investigations for national and international companies; represented parties in qui tam actions; assisted companies and individuals in responding to federal and state governmental investigations; and represented companies in both antitrust litigation and merger investigations. 

Thought Leadership


  • Co-author, "Feature Comment: Lessons Learned On The Second Anniversary Of Universal Health Servs., Inc. v. U.S. ex rel. Escobar," The Government Contractor, Vol. 60, No. 21, June 6, 2018
  • Co-editor, The Antitrust Review, 2004-2012
  • "Digital Evidence in Competition Investigations: National Comparisons (United States)," Concurrences Review, November 2009 
  • "Dr. Miles: Will The Supreme Court Find a Cure?," The Antitrust Source, February 2007
  • "Cardizem CD®, K-Dur®, Plavix®, and OxyContin®: Have We Entered The Endgame of Antitrust Uncertainty Towards Pharmaceutical Patent Litigation Settlements?," Health Lawyers Weekly, Vol. 4, No. 48, American Health Lawyers Association, December 15, 2006

False Claims Act Defense Blog Posts

Healthcare Law Blog Posts

Media Mentions

Speaking Engagements

  • "What Circuits and District Courts the Relators and Defense Favor and Those They Try to Avoid," ACI’s Life Sciences & Healthcare False Claims Litigation, May 22, 2018
  • "Substantive and Procedural Motions," District of Columbia Bar Association CLE Program Pre-Trial Skills Series, October 22, 2009, October 29, 2010 & October 20, 2011, November 29, 2012, November 13, 2013, November 6, 2014, November 12, 2015, and November 29, 2016
  • "Damages: How Big or Small Is Your Case," ABA National False Claims Act and Qui Tam Trial Institute, June 6, 2013
  • "Reimbursement and False Claims Act Fundamentals," ABA Health Law Section, May 19, 2011 and February 7, 2013
  • "In-House Counsel Update," ABA Section of Antitrust Law Corporate Counseling Committee, June 2, 2011
  • "False Claims Act Changes and Challenges," Department of Energy Contractor Attorneys' Association's (DOECAA) Spring Conference, May 13, 2010
  • "The Government's Crackdown on Clinical Research Misconduct," Drug Information Association's Liability Risks in Clinical Trials Program, February 25, 2010


  • Board of Directors, Clarendon Child Care Center
  • Editorial Advisory Board for Competition Law360, 2010-2011